Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples